- Komodo Health recently announced that it raised $220 million in Series E funding. These are the details.
Komodo Health recently announced that it raised $220 million in Series E funding led by Tiger Global Management and joined by Casdin Capital. The company’s Existing investors ICONIQ Growth, Andreessen Horowitz, and SVB Capital also joined the round. And this investment underscores Komodo Heath’s rapidly growing role as a foundational enterprise technology platform helping to drive digital transformation across the healthcare industry.
This additional funding will enable Komodo Health to accelerate investment in its enterprise technology platform, application suite, and core data assets. And Komodo Health has created a standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with enterprise cloud technologies that connect the dots between individual patient journeys and large-scale health outcomes.
This combination of clinical insights and the ability to infuse them into enterprise workflows is helping the world’s leading life sciences companies, health plans, and patient advocacy groups close the gaps in care, address unmet patient needs, improve engagement, and help drive novel therapies into the market.
Launched in 2014, Komodo Health’s mission is to reduce the global burden of disease. And the company’s Healthcare Map is the foundation of its enterprise technology platform. Plus the industry’s largest and most complete record of de-identified, real-world patient insights, the Healthcare Map uses AI and advanced data analytics to track encounters with the healthcare system for over 325 million patients.
By drawing from across the whole healthcare system, Komodo’s Healthcare Map is the only system of insight of its kind to provide a longitudinal view of the patient journey at scale.
“This investment reaffirms our patient-centric approach to understanding every interaction with the healthcare system and building a flexible analytics platform based on that foundation. As digital adoption continues to accelerate rapidly and new sources of healthcare insights proliferate, Komodo enables the enterprise to address unmet needs of patients while reducing disparities in care.”
— Arif Nathoo, MD, co-founder and CEO, Komodo Health
“Komodo Health’s track record of growth speaks to their success in driving transformational changes that win in the market. We expect that growth to accelerate as the company introduces simplicity and intelligence in an enterprise platform that is built for scale and impact.”
— John Curtius, partner, Tiger Global
“We had a vision seven years ago that integrating robust data with software solutions was the way forward for healthcare at a time when no one was doing this. Komodo’s Healthcare Map is now the deepest, most representative, and most powerful engine of healthcare intelligence, and as we build for the future, we are humbled to add Tiger Global and Casdin Capital to the list of premier investors backing us in our relentless effort to further extend our seven-year lead.”
— Web Sun, co-founder and president, Komodo Health
“As long-time investors in the intersection of Life Sciences and next-generation technologies, it was quickly clear to us the scale advantage and impact potential of Komodo Health. They are already far ahead of legacy aggregators and increasingly becoming a leading partner in helping accelerate top pharma and emerging biotechnology companies’ novel therapies to market. We’re thrilled to partner with their outstanding leadership team and help bring their vision to life.”
— Eli Casdin, founder, Casdin Capital